Insulet reported $320.4M in Stock for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Atricure ATRC:US $ 41.29M 0.53M
Avanos Medical Inc AVNS:US $ 169M 11.4M
Baxter International BAX:US $ 2663M 115M
Becton, Dickinson and BDX:US $ 3163M 95M
Cardinal Health CAH:US 15.64B 143M
Cardiovascular Systems CSII:US $ 34.57M 1.71M
Cooper Companies COO:US $ 621.6M 17.8M
Dexcom DXCM:US $ 339.5M 2.7M
Edwards Lifesciences EW:US $ 740M 9.4M
Eli Lilly And LLY:US $ 3899.4M 6.4M
Globus Medical GMED:US $ 266.04M 12.16M
Icu Medical ICUI:US $ 583.05M 46.74M
Inogen INGN:US $ 33.5M 0.58M
Insulet PODD:US $ 320.4M 5.6M
Masimo MASI:US $ 449.2M 235.72M
Medtronic MDT:US $ 4809M 193M
Nuvasive NUVA:US $ 331.71M 7.3M
Stryker SYK:US $ 3749M 224M
Teleflex TFX:US $ 510.53M 19.11M
West Pharmaceutical Services WST:US $ 411.6M 4.9M
Zimmer Biomet Holdings Inc ZBH:US $ 2.12B 9.4M